miR-145 inhibits colorectal cancer progression and metastasis by targeting SNAI1 and the cAMP/PKA pathway
Advances in Clinical and Experimental Medicine · 29.06.2026 · 35 (6) · 1047-1061
DOI: 10.17219/acem/210638 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical and Experimental Medicine, online erschienen am 29.06.2026. Verfasst von Jianshan Cai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Snail Family Transcription Factors, MicroRNAs, Cyclic AMP-Dependent Protein Kinases, Cyclic AMP. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China.
- Department of General Surgery, Jing'an District Center Hospital of Shanghai, China.
Zitieren
APA
Cai, J., Sun, Q., Deng, S., Wei, Q., Li, L., Ma, B., & Chen, J. (2026). miR-145 inhibits colorectal cancer progression and metastasis by targeting SNAI1 and the cAMP/PKA pathway. Advances in Clinical and Experimental Medicine, 35(6), 1047-1061. https://doi.org/10.17219/acem/210638
Vancouver
Cai J, Sun Q, Deng S, Wei Q, Li L, Ma B, et al. miR-145 inhibits colorectal cancer progression and metastasis by targeting SNAI1 and the cAMP/PKA pathway. Advances in Clinical and Experimental Medicine. 2026;35(6):1047-1061. doi:10.17219/acem/210638
BibTeX
@article{Cai2026,
author = {Cai, Jianshan and Sun, Qiang and Deng, Shichao and Wei, Qi and Li, Longzhi and Ma, Baojin and Chen, Jiadong},
title = {miR-145 inhibits colorectal cancer progression and metastasis by targeting SNAI1 and the cAMP/PKA pathway},
journal = {Advances in Clinical and Experimental Medicine},
year = {2026},
volume = {35},
number = {6},
pages = {1047--1061},
doi = {10.17219/acem/210638}
}
EUVIMED